DR.REDDYS LABORATORIES LTD.DR.REDDYS LABORATORIES LTD.DR.REDDYS LABORATORIES LTD.

DR.REDDYS LABORATORIES LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.11 T‬INR
‪55.68 B‬INR
‪279.16 B‬INR
‪121.84 M‬
Beta (1Y)
0.75

About DR REDDYS LABS

CEO
Erez Israeli
Headquarters
Hyderabad
Employees (FY)
‪27.05 K‬
Founded
1984
ISIN
INE089A01023
FIGI
BBG000CQNBN3
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DRREDDY is 6,639.05 INR — it has decreased by 0.39% in the past 24 hours. Watch DR.REDDYS LABORATORIES LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange DR.REDDYS LABORATORIES LTD. stocks are traded under the ticker DRREDDY.
DRREDDY stock has risen by 0.61% compared to the previous week, the month change is a 10.69% rise, over the last year DR.REDDYS LABORATORIES LTD. has showed a 27.04% increase.
We've gathered analysts' opinions on DR.REDDYS LABORATORIES LTD. future price: according to them, DRREDDY price has a max estimate of 7,941.00 INR and a min estimate of 4,245.00 INR. Watch DRREDDY chart and read a more detailed DR.REDDYS LABORATORIES LTD. stock forecast: see what analysts think of DR.REDDYS LABORATORIES LTD. and suggest that you do with its stocks.
DRREDDY reached its all-time high on Jul 12, 2024 with the price of 6,741.90 INR, and its all-time low was 306.50 INR and was reached on May 9, 2005. View more price dynamics on DRREDDY chart.
See other stocks reaching their highest and lowest prices.
DRREDDY stock is 1.31% volatile and has beta coefficient of 0.75. Track DR.REDDYS LABORATORIES LTD. stock price on the chart and check out the list of the most volatile stocks — is DR.REDDYS LABORATORIES LTD. there?
Today DR.REDDYS LABORATORIES LTD. has the market capitalization of ‪1.11 T‬, it has increased by 1.72% over the last week.
Yes, you can track DR.REDDYS LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
DR.REDDYS LABORATORIES LTD. is going to release the next earnings report on Jul 27, 2024. Keep track of upcoming events with our Earnings Calendar.
DRREDDY earnings for the last quarter are 78.35 INR per share, whereas the estimation was 73.50 INR resulting in a 6.60% surprise. The estimated earnings for the next quarter are 79.26 INR per share. See more details about DR.REDDYS LABORATORIES LTD. earnings.
DR.REDDYS LABORATORIES LTD. revenue for the last quarter amounts to ‪70.83 B‬ INR, despite the estimated figure of ‪70.67 B‬ INR. In the next quarter, revenue is expected to reach ‪72.98 B‬ INR.
DRREDDY net income for the last quarter is ‪13.07 B‬ INR, while the quarter before that showed ‪13.79 B‬ INR of net income which accounts for −5.21% change. Track more DR.REDDYS LABORATORIES LTD. financial stats to get the full picture.
Yes, DRREDDY dividends are paid annually. The last dividend per share was 40.00 INR. As of today, Dividend Yield (TTM)% is 0.60%. Tracking DR.REDDYS LABORATORIES LTD. dividends might help you take more informed decisions.
DR.REDDYS LABORATORIES LTD. dividend yield was 0.65% in 2023, and payout ratio reached 11.95%. The year before the numbers were 0.87% and 14.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 20, 2024, the company has ‪27.05 K‬ employees. See our rating of the largest employees — is DR.REDDYS LABORATORIES LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR.REDDYS LABORATORIES LTD. EBITDA is ‪76.93 B‬ INR, and current EBITDA margin is 28.20%. See more stats in DR.REDDYS LABORATORIES LTD. financial statements.
Like other stocks, DRREDDY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR.REDDYS LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR.REDDYS LABORATORIES LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR.REDDYS LABORATORIES LTD. stock shows the strong buy signal. See more of DR.REDDYS LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.